|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date01 Jan 1966 |
Target- |
Mechanism- |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date16 Jul 1953 |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingNot Applicable A Randomized, Double-Blind, Crossover Study to Assess the Comparative Bioavailability of a Lutein, Zeaxanthin, and Astaxanthin Complex with LuZeAbility Capsule in Healthy Adult Volunteers. - NIL
100 Clinical Results associated with Daihan Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Daihan Pharmaceutical Co., Ltd.
100 Deals associated with Daihan Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Daihan Pharmaceutical Co., Ltd.